Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Prostatic Neoplasms 20Lung Neoplasms 18Glioma 13Neoplasm Metastasis 11Carcinoma, Non-Small-Cell Lung 11Breast Neoplasms 11Urinary Bladder Neoplasms 10Pancreatic Neoplasms 10Multiple Myeloma 10Lymphoma 10Squamous Cell Carcinoma of Head and Neck 9Mouth Neoplasms 9Colorectal Neoplasms 8Carcinoma, Renal Cell 8Ovarian Neoplasms 7Oropharyngeal Neoplasms 7Melanoma 7Laryngeal Neoplasms 7Glioblastoma 7Carcinoma, Hepatocellular 7Carcinoma 7Wilms Tumor 6Sarcoma 6Neuroblastoma 6Nasopharyngeal Carcinoma 6Medulloblastoma 6Lymphoma, Non-Hodgkin 6Fallopian Tube Neoplasms 6Triple Negative Breast Neoplasms 5Rhabdoid Tumor 5

Interventions

Vincristine 5merphos 4Methotrexate 4Dexamethasone 4Cytarabine 4Cyclophosphamide 4pegaspargase 3dexamethasone acetate 3dexamethasone 21-phosphate 3blinatumomab 3azathiopurine 3auricularum 3Mercaptopurine 3Leucovorin 3Doxorubicin 3Calcium Dobesilate 3prednylidene 2deltacortene 2asparaginase erwinia chrysanthemi recombinant 2Thioguanine 2Spinal Puncture 2Specimen Handling 2Prednisone 2N,N-dicyclohexyl-isoborneol-10-sulfonamide 2Inotuzumab Ozogamicin 2Asparaginase 2venetoclax 1ofatumumab 1calaspargase pegol 1X-Rays 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma × Magnetic Resonance Spectroscopy × 30 days × Clear all
NCT03504644 2026-05-29

Venetoclax and Vincristine in Treating Patients With Relapsed or Refractory T-cell or B-cell Acute Lymphoblastic Leukemia

Eastern Cooperative Oncology Group

Phase 1/2 Active not recruiting
40 enrolled 18 charts
LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡